NOK Operating Cash Flow (Statement)

Nokia Corporation Sponsored American Depositary Shares · Operating Cash Flow (Statement)

NOK logo

NOK Operating Cash Flow (Statement)

Latest reported€1.14B EUR
NOK TTM Cash from Operations · EUR (€3.11B → €1.14B)
High-resolution chart · PNG

NOK operating cash flow (statement) history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Nokia Corporation Sponsored American Depositary Shares Operating Cash Flow (Statement) — Trailing twelve months (TTM) (EUR)
Period endingOperating Cash Flow (Statement) (EUR)
1,135,000,000
1,964,000,000
2,071,000,000
1,904,000,000
2,102,213,484
2,382,213,484
2,559,213,484
4,221,213,484
3,123,000,000
2,301,000,000
1,317,000,000
14,000,000
708,000,000
998,000,000
1,474,000,000
1,393,000,000
1,731,000,000
1,880,000,000
2,625,000,000
3,018,000,000
2,702,000,000
2,929,000,000
1,759,000,000
2,670,279,702
2,721,279,702
1,472,279,702
591,279,702
187,000,000
-359,000,000
-277,000,000
360,000,000
964,000,000
302,000,000
2,175,000,000
1,812,000,000
332,000,000
1,310,000,000
-345,000,000
-1,455,000,000
-1,505,000,000
-1,236,000,000
-878,000,000
506,000,000
270,000,000
166,000,000
1,214,000,000
1,275,000,000
1,104,000,000
714,000,000
-272,000,000
72,000,000
582,000,000
144,000,000
442,000,000
-354,000,000
-283,000,000
998,000,000
720,000,000
1,137,000,000
2,939,000,000
2,526,000,000
3,646,000,000
4,774,000,000
3,873,000,000
4,154,000,000
3,926,000,000
3,247,000,000
1,424,778,530
1,982,606,940
2,723,852,690
3,204,514,740
6,217,921,160
6,930,821,730
7,010,182,230
7,894,363,700
6,829,957,610
5,791,244,470
5,151,879,700
4,477,947,900
3,878,768,710
4,150,436,590
3,759,719,750
4,140,496,240
3,846,304,630
3,807,430,050
4,676,131,290
4,339,771,440
4,850,856,820
4,896,934,180
4,865,255,900
5,235,039,790
5,298,423,970
6,229,321,270
6,292,432,770
5,818,834,820
6,817,706,350
6,361,323,850
5,741,788,650
6,558,014,850
5,388,555,200
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.